Day Cheryl L, Njuguna Irene N, Cranmer Lisa Marie, Whatney Wendy E, Pearson Rachel A, Lindestam Arlehamn Cecilia S, Sette Alessandro, LaCourse Sylvia M, Escudero Jaclyn N, Sasser Loren E, Mugo Cyrus, Okinyi Hellen Moraa, Maleche-Obimbo Elizabeth, Wamalwa Dalton C, John-Stewart Grace C
Department of Microbiology and Immunology, Emory University School of Medicine.
Emory Vaccine Center, Emory University, Atlanta, Georgia.
J Infect Dis. 2025 Apr 15;231(4):957-966. doi: 10.1093/infdis/jiae630.
Despite immune restoration after initiation of antiretroviral treatment (ART), the risk of tuberculosis (TB) persists in children with HIV (CHIV). We determined patterns of immune restoration of mycobacteria-specific T cells following ART in CHIV.
CD4 and CD8 T-cell activation and memory phenotype and functional profiles before and 6 months after ART were evaluated in peripheral blood mononuclear cells from CHIV enrolled in the PUSH study (NCT02063880) in Nairobi, Kenya. T-cell expression of cytokines and activation-induced markers were measured following stimulation of peripheral blood mononuclear cells with a pool of 300 peptides from TB (MTB300) or staphylococcal enterotoxin B.
Among 47 CHIV (median age, 1.5 years), staphylococcal enterotoxin B-induced Th1 cytokine+ and activation-induced marker+ CD4 cell frequencies increased significantly after 6 months of ART. Although MTB300-specific CD4 and CD8 cell frequency did not increase after ART, polyfunctional capacity of MTB300-specific CD4 cells expressing combinations of Th1 cytokines with CD40L increased significantly after ART. Baseline age, immune activation, and effector memory CD4 levels were associated with less restoration of MTB300-specific polyfunctional CD4 cells, whereas CD4 percentage and levels of naive CD4 cells following ART were associated with improved MTB300-specific polyfunctional capacity.
Despite increases in Th1 cytokine production, deficits in mycobacteria-specific CD4 cells persisted 6 months after ART, with higher deficits in older CHIV with more immunosuppression, higher immune activation, and lower proportion of naive CD4 cells. These findings may explain persistent TB risk during early ART among CHIV and identify those at highest risk.
尽管开始抗逆转录病毒治疗(ART)后免疫功能得以恢复,但感染人类免疫缺陷病毒(HIV)的儿童(CHIV)仍有患结核病(TB)的风险。我们确定了CHIV接受ART后分枝杆菌特异性T细胞的免疫恢复模式。
在肯尼亚内罗毕参加PUSH研究(NCT02063880)的CHIV的外周血单核细胞中,评估ART前及ART后6个月时CD4和CD8 T细胞的活化、记忆表型及功能特征。用来自结核分枝杆菌的300种肽段组合(MTB300)或葡萄球菌肠毒素B刺激外周血单核细胞后,检测细胞因子的T细胞表达及活化诱导标志物。
在47例CHIV(中位年龄1.5岁)中,ART 6个月后,葡萄球菌肠毒素B诱导的Th1细胞因子阳性和活化诱导标志物阳性的CD4细胞频率显著增加。虽然ART后MTB300特异性CD4和CD8细胞频率未增加,但表达Th1细胞因子与CD40L组合的MTB300特异性CD4细胞的多功能能力在ART后显著增加。基线年龄、免疫活化及效应记忆CD4水平与MTB300特异性多功能CD4细胞恢复较差有关,而ART后CD4百分比及初始CD4细胞水平与MTB300特异性多功能能力改善有关。
尽管Th1细胞因子产生增加,但ART 6个月后分枝杆菌特异性CD4细胞仍有缺陷,年龄较大、免疫抑制更严重、免疫活化更高及初始CD4细胞比例更低的CHIV缺陷更明显。这些发现可能解释了CHIV在ART早期持续存在的结核病风险,并确定了高危人群。